Follows positive opinion issued by EMA’s CHMP
News
Roche’s faricimab hits the mark in diabetic macular edema study
Treatment demonstrated non-inferior visual acuity gains compared to Regeneron’s Eylea
Green light for AZ’s Tagrisso in early-stage lung cancer
EGFR-TKI approved in the US for early non-small cell lung cancer
Aimmune’s peanut allergy med Palforzia wins EU approval
Drug becomes first treatment for peanut allergy in the EU
US approves Moderna’s COVID-19 vaccine for emergency use
Company will immediately begin delivering doses to the US government
Scancell picks lead COVID-19 vaccine candidate
SN14 will be advanced through further development and clinical trials
GSK co-leads investment in ‘disease rebalancing’ Adrestia Therapeutics
British pharma company also announces strategic collaboration agreement
Novo Nordisk eyes EU approval for once-weekly semaglutide
Danish pharma is seeking approval for drug as a weight management therapy
NHS England invests £10m in network of ‘long COVID’ clinics
Specialist help will be available at 69 sites across the country
PharmaTimes are excited to announce the launch of INTCR 2021
Flying the flag for excellence in global clinical research, the prestigious PharmaTimes International Clinical Researcher of the Year opens its doors for entry.
EUSA Pharma launches phase III COVID-19 study for siltuximab
Study will enrol hospitalised COVID-19 patients with serious viral acute respiratory distress syndrome
International consortium creates ‘open platform’ for COVID-19 drug discovery
Consortium is led by Cambridge Medical Research Council (MRC) researchers
Kite’s CAR T therapy Tecartus authorised in EU for MCL
CHMP backed the CAR T cell therapy for the treatment of mantle cell lymphoma back in October
Valneva starts UK-based early-stage COVID-19 vaccine trial
French biotech will test vaccine candidate on 150 volunteers across four sites
NICE recommends Novartis’ wet AMD drug Beovu
Final appraisal determination recommends anti-VEGF treatment for NHS use
